Economic burden of patients with leading cancers in China: a cost-of-illness study

Ziting Wu,Yiwen Yu,Feng Xie,Qiushi Chen,Zhong Cao,Simiao Chen,Gordon G. Liu
DOI: https://doi.org/10.1186/s12913-024-11514-x
2024-09-28
BMC Health Services Research
Abstract:China accounts for 24% of newly diagnosed cancer cases and 30% of cancer-related deaths worldwide. Comprehensive analyses of the economic burden on patients across different cancer treatment phases, based on empirical data, are lacking. This study aims to estimate the financial burden borne by patients and analyze the cost compositions of the leading cancers with the highest number of new cases in China.
health care sciences & services
What problem does this paper attempt to address?